Transcription assay

As expected, in vitro transcription assays involving PARP-1, NAD, and PARC illustrate these predicted outcomes (Kim et al, 2004). Even when driven by a transcriptional activator, such as estradiol-bound estrogen receptor, transcription is repressed when PARP-1 is added to chromatin templates. The repression is reversed by NAD+, and the NAD+-dependent effects are reversed by PARC (Kim et al, 2004). This system for transcriptional control shifts new importance onto the enzymes responsible for synthesis of NAD+ in the nucleus, such as nicotinamide mononucleotide adenylyltransferase-1 (Magni et al, 2004). Because NAD+ facilitates the decompaction of chromatin and the derepression of transcription, nuclear NAD+ biosynthetic enzymes may play critical roles as cofactors. 

Anti-androgenic effect. Sterol fraction of the dried fruit, in cell culture, was active on CA-PC3 and reduced androgen-induced reporter gene expression in transcriptional assay IC50 50 pg/mL . Administration to... 

It has been established that the activity of both NR and NiR is induced by nitrate in plants (Rajasekhar Oelmuller, 1987), even if in a few species constitutive NR and NiR isoforms are found in addition to the inducible ones. Nitrate supply leads to an increase in the steady-state level of mRNA encoding NR in a variety of plant species and tissues (Cheng et al., 1986, 1991 Crawford et al., 1986 Smarrelli et al., 1987 Galangau et al., 1988 Gowri Campbell, 1989 Hamat et al., 1989 Hoff et al., 1991 Friemann et al., 1991). This in turn results in NR protein synthesis and increased activity, shortly after nitrate supply to the roots, and after a lag in leaves (Melzer et al., 1989). Where performed, nuclear runoff transcription assays have indicated that the high mRNA level results from increased transcriptional activity (Callaci Smarrelli, 1991 Lillo, 1991). 

Gaido, K.W., Leonard, L.S., Lovell, S., Gould, J.C., Babai, D., Portier, C.J., and McDonnell, D.P., Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay, Toxicol. Appl. Pharmacol., 143, 205-212, 1997. 

FIGURE 11.4 Schematic representation of a transcription assay. Cells are engineered by placing the luciferase-encoding gene under the control of a promoter of interest. Each microwell contains the same amount of cells, which are exposed to different samples and incubated for the required time. After the appropriate incubation, the sample is washed out and the light emitted by luciferase is measured. 

More recently Michnick and co-workers have introduced a dihydrofolate reductase complementation system, which seems to be particularly robust [61 - 65], They attribute the success of this system to the fact that the N-terminal (1 - 105) and C-terminal (106 - 186) DHFR fragments do not fold until they are dimerized. In addition to the obvious selection for essential metabolites dependent on the reduction of dihydrofolate to tetrahydrofolate, protein-protein interactions are detected based on the retention of a fluorescein-methotrexate conjugate. Several other enzymes have been employed for the design of complementation assays, including green fluorescent protein, which allows screens based on fluorescence or FRET [66 - 68]. As with the bacterial transcription assays, these complementation systems are new. It will be interesting to see if, as the selections are optimized, these systems prove competitive with the Y2H assay. 

The isoxazolidine ring was used as a scaffold for the design and construction of artificial small molecule activation domains. In particular, the amphipathic isoxazolidines 109 were shown to be nearly as active as the natiual activation peptide ATF14 in in vitro transcription assays <05JA12456>. 

Similar In vitro transcription assays with other cloned eukaryotic genes have produced similar results. In each case, the start site was found to be equivalent to the capped 5 sequence of the corresponding mRNA. Thus synthesis of eukaryotic precursors of mRNAs by RNA polymerase II begins at the DNA sequence encoding the capped 5 end of the mRNA. Today, the transcription start site for a newly characterized mRNA generally is determined simply by identifying the DNA sequence encoding the 5 end of the mRNA. 

---